{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:52:30Z","timestamp":1787737950285,"version":"build-2784847793"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,8,22]],"date-time":"2011-08-22T00:00:00Z","timestamp":1313971200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>According to the very limited cancer registry, incidence and mortality rates for female breast cancer in China are regarded to be increasing especially in the metropolitan areas. Representative data on the breast cancer profile of Chinese women and its time trend over years are relatively rare. The aims of the current study are to illustrate the breast cancer profile of Chinese women in time span and to explore the current treatment approaches to female breast cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This was a hospital-based nation-wide and multi-center retrospective study of female primary breast cancer cases. China was divided into 7 regions according to the geographic distribution; from each region, one tertiary hospital was selected. With the exception of January and February, one month was randomly selected to represent each year from year 1999 to 2008 at every hospital. All inpatient cases within the selected month were reviewed and related information was collected based on the designed case report form (CRF). The Cancer Hospital\/Institute, Chinese Academy of Medical Sciences (CICAMS) was the leading hospital in this study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Four-thousand two-hundred and eleven cases were randomly selected from the total pool of 45,200 patients and were included in the analysis. The mean age at diagnosis was 48.7 years (s.d. = 10.5 yrs) and breast cancer peaked in age group 40-49 yrs (38.6%). The most common subtype was infiltrating ductal carcinoma (86.5%). Clinical stage I &amp; II accounted for 60.6% of 4,211 patients. Three-thousand five-hundred and thirty-four cases had estrogen receptor (ER) and progestin receptor (PR) tests, among them, 47.9% were positive for both. Two-thousand eight-hundred and forty-nine cases had human epidermal growth factor receptor 2(HER-2) tests, 25.8% of them were HER-2 positive. Among all treatment options, surgery (96.9% (4,078\/4,211)) was predominant, followed by chemotherapy (81.4% (3,428\/4,211). Much less patients underwent radiotherapy (22.6% (952\/4,211)) and endocrine therapy (38.0% (1,599\/4,211)).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The younger age of breast cancer onset among Chinese women and more advanced tumor stages pose a great challenge. Adjuvant therapy, especially radiotherapy and endocrine therapy are of great unmet needs.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1471-2407-11-364","type":"journal-article","created":{"date-parts":[[2011,8,23]],"date-time":"2011-08-23T06:33:00Z","timestamp":1314081180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":186,"title":["A Nation-Wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in china"],"prefix":"10.1186","volume":"11","author":[{"given":"Jing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Lian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ming","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Hua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Jun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Lin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,22]]},"reference":[{"key":"2865_CR1","volume-title":"Lyon, France: International Agency for Research on Cancer","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer. 2010"},{"key":"2865_CR2","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1158\/1055-9965.EPI-10-0437","volume":"19","author":"A Jemal","year":"2010","unstructured":"Jemal A, Center MM, DeSantis C, Ward EM: Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010, 19: 1893-1907. 10.1158\/1055-9965.EPI-10-0437.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2865_CR3","first-page":"26","volume-title":"Book [Chinese Cancer Registry Annual Report 2009]","author":"XY Chen","year":"2010","unstructured":"Chen XY, Kong ZL: [Chinese Cancer Registry Annual Report 2009]. Book [Chinese Cancer Registry Annual Report 2009]. 2010, City: Military Medical Science Press, 26-28. (Editor ed.^eds.)."},{"key":"2865_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/000313489906500101","volume":"65","author":"CR Scoggins","year":"1999","unstructured":"Scoggins CR, Vitola JV, Sandler MP, Atkinson JB, Frexes-Steed M: Occult breast carcinoma presenting as an axillary mass. Am Surg. 1999, 65: 1-5.","journal-title":"Am Surg"},{"key":"2865_CR5","volume-title":"Histological typing of breast tumors","author":"WHO","year":"1981","unstructured":"WHO: Histological typing of breast tumors. 1981, Geneva: WHO, 2","edition":"2"},{"key":"2865_CR6","volume-title":"Pathology and genetics of tumours of the breast and female genital organs","author":"FA Tavassoli","year":"2003","unstructured":"Tavassoli FA, Devilee P: Pathology and genetics of tumours of the breast and female genital organs. 2003, Lyon: World Health Organization"},{"key":"2865_CR7","volume-title":"AJCC cancer staging manual","author":"ID Fleming","year":"1997","unstructured":"Fleming ID, American Joint Committee on Cancer: AJCC cancer staging manual. 1997, Philadelphia: Lippincott-Raven Philadelphia, 5","edition":"5"},{"key":"2865_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3656-4","volume-title":"AJCC cancer staging manual","author":"FL Greene","year":"2002","unstructured":"Greene FL, American Joint Committee on Cancer: AJCC cancer staging manual. 2002, New York: Springer Verlag, 6","edition":"6"},{"key":"2865_CR9","first-page":"142","volume":"5","author":"JQ Luo","year":"1999","unstructured":"Luo JQ, Su HM, Meng X: [Anlysis of incidence rate of femal breast cancer patients in Wuzhou City from 1981 to 1996.]. Guangxi Prev Med. 1999, 5: 142-","journal-title":"Guangxi Prev Med"},{"key":"2865_CR10","first-page":"327","volume-title":"Chinese Journal of Cancer","author":"MT Yang","year":"2005","unstructured":"Yang MT, Rong TH, Huang ZF, Zeng CG, Long H, Fu JH, Lin P, Wang X, Wang SY, Wang X: [Clinical Analysis of Resectable Breast Cancer: a Report of 6 263 Cases]. Chinese Journal of Cancer. 2005, 327-331."},{"key":"2865_CR11","first-page":"1264","volume-title":"The Journal of Medical Theory and Practice","author":"WL Li","year":"2006","unstructured":"Li WL, Wu JM, Liu G, Zhong QS: [Clinical Analysis on Expression of Estrogen and Progesterone Receptors in Breast Cancer (A Report of 836 Cases)]. The Journal of Medical Theory and Practice. 2006, 1264-1266."},{"key":"2865_CR12","volume-title":"Master. Guangxi Medical University","author":"YH Tu","year":"2007","unstructured":"Tu YH: [Clinical and Pathological Characteristics of Breast Cancer: A Report of 292 Cases.]. Master. Guangxi Medical University. 2007"},{"key":"2865_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/sj.bjc.6604898","volume":"100","author":"WH Kuo","year":"2009","unstructured":"Kuo WH, Yen AM, Lee PH, Chen KM, Wang J, Chang KJ, Chen TH, Tsau HS: Cumulative survival in early-onset unilateral and bilateral breast cancer: an analysis of 1907 Taiwanese women. Br J Cancer. 2009, 100: 563-570. 10.1038\/sj.bjc.6604898.","journal-title":"Br J Cancer"},{"key":"2865_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1524-4741.2010.00903.x","volume":"16","author":"WL Lu","year":"2010","unstructured":"Lu WL, Li HX, Qian BY, Wang Y, Jansen L, Huang GW, Tang NJ, Sun Z, Chen KX, De Bock GH: The clinical characteristics and prognosis of Chinese early stage breast cancer patients: a retrospective study. Breast J. 2010, 16: 331-333. 10.1111\/j.1524-4741.2010.00903.x.","journal-title":"Breast J"},{"issue":"Suppl 1","key":"2865_CR15","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1111\/j.1075-122X.2006.00205.x","volume":"12","author":"DM Parkin","year":"2006","unstructured":"Parkin DM, Fernandez LM: Use of statistics to assess the global burden of breast cancer. Breast J. 2006, 12 (Suppl 1): S70-80.","journal-title":"Breast J"},{"key":"2865_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/1471-2407-7-222","volume":"7","author":"N Elkum","year":"2007","unstructured":"Elkum N, Dermime S, Ajarim D, Al-Zahrani A, Alsayed A, Tulbah A, Al Malik O, Alshabanah M, Ezzat A, Al-Tweigeri T: Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experience. BMC Cancer. 2007, 7: 222-10.1186\/1471-2407-7-222.","journal-title":"BMC Cancer"},{"key":"2865_CR17","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1002\/bjs.5834","volume":"94","author":"K Lavelle","year":"2007","unstructured":"Lavelle K, Moran A, Howell A, Bundred N, Campbell M, Todd C: Older women with operable breast cancer are less likely to have surgery. Br J Surg. 2007, 94: 1209-1215. 10.1002\/bjs.5834.","journal-title":"Br J Surg"},{"key":"2865_CR18","unstructured":"Ries L, Melbert D, Krapcho M, Stinchcomb D, Howlader N, Horner M, Mariotto A, Miller B, Feuer E, Altekruse S: SEER Cancer Statistics Review, 1975-2005. National Cancer Institute. Bethesda, MD, Available at seer cancer gov\/csr\/1975_2005\/, based on November 2007"},{"key":"2865_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1015-9584(10)60017-6","volume":"33","author":"R Wei","year":"2010","unstructured":"Wei R, Lau SS, Cheung PS: Breast carcinoma in Chinese women: does age affect treatment choice and outcome?. Asian J Surg. 2010, 33: 97-102. 10.1016\/S1015-9584(10)60017-6.","journal-title":"Asian J Surg"},{"key":"2865_CR20","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s00268-007-9086-3","volume":"31","author":"SE Lim","year":"2007","unstructured":"Lim SE, Back M, Quek E, Iau P, Putti T, Wong JE: Clinical observations from a breast cancer registry in Asian women. World J Surg. 2007, 31: 1387-1392. 10.1007\/s00268-007-9086-3.","journal-title":"World J Surg"},{"key":"2865_CR21","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1002\/1097-0142(19940401)73:7<1994::AID-CNCR2820730735>3.0.CO;2-O","volume":"73","author":"RT Osteen","year":"1994","unstructured":"Osteen RT, Karnell LH: The National Cancer Data Base report on breast cancer. Cancer. 1994, 73: 1994-2000. 10.1002\/1097-0142(19940401)73:7<1994::AID-CNCR2820730735>3.0.CO;2-O.","journal-title":"Cancer"},{"key":"2865_CR22","first-page":"209","volume":"24","author":"ID Gukas","year":"2005","unstructured":"Gukas ID, Jennings BA, Mandong BM, Igun GO, Girling AC, Manasseh AN, Ugwu BT, Leinster SJ: Clinicopathological features and molecular markers of breast cancer in Jos, Nigeria. West Afr J Med. 2005, 24: 209-213.","journal-title":"West Afr J Med"},{"key":"2865_CR23","first-page":"92","volume":"51","author":"B Sarre","year":"2006","unstructured":"Sarre B, Ogougbemy M, Dotou C, Lopy J, Ndionne P, Frank K, Drave K, Diouf MB: [Epidemiological, therapeutic and prognostic aspects of breast cancer: about 473 cases collected in Hopital Principal de Dakar]. Dakar Med. 2006, 51: 92-96.","journal-title":"Dakar Med"},{"key":"2865_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/pon.1144","volume":"16","author":"A Ekortarl","year":"2007","unstructured":"Ekortarl A, Ndom P, Sacks A: A study of patients who appear with far advanced cancer at Yaounde General Hospital, Cameroon, Africa. Psychooncology. 2007, 16: 255-257. 10.1002\/pon.1144.","journal-title":"Psychooncology"},{"key":"2865_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3233\/BD-2009-0296","volume":"31","author":"AM Burson","year":"2010","unstructured":"Burson AM, Soliman AS, Ngoma TA, Mwaiselage J, Ogweyo P, Eissa MS, Dey S, Merajver SD: Clinical and epidemiologic profile of breast cancer in Tanzania. Breast Dis. 2010, 31: 33-41.","journal-title":"Breast Dis"},{"key":"2865_CR26","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/ije\/27.5.735","volume":"27","author":"S Shapiro","year":"1998","unstructured":"Shapiro S, Coleman EA, Broeders M, Codd M, de Koning H, Fracheboud J, Moss S, Paci E, Stachenko S: Ballard-Barbash R: Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening. Int J Epidemiol. 1998, 27: 735-742. 10.1093\/ije\/27.5.735.","journal-title":"Int J Epidemiol"},{"key":"2865_CR27","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1089\/jwh.2008.1127","volume":"18","author":"L Vona-Davis","year":"2009","unstructured":"Vona-Davis L, Rose DP: The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. J Womens Health (Larchmt). 2009, 18: 883-893. 10.1089\/jwh.2008.1127.","journal-title":"J Womens Health (Larchmt)"},{"key":"2865_CR28","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1002\/cncr.21030","volume":"103","author":"VR Grann","year":"2005","unstructured":"Grann VR, Troxel AB, Zojwalla NJ, Jacobson JS, Hershman D, Neugut AI: Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma. Cancer. 2005, 103: 2241-2251. 10.1002\/cncr.21030.","journal-title":"Cancer"},{"key":"2865_CR29","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1158\/1078-0432.CCR-07-1127","volume":"14","author":"DC Allred","year":"2008","unstructured":"Allred DC, Wu Y, Mao S, Nagtegaal ID, Lee S, Perou CM, Mohsin SK, O'Connell P, Tsimelzon A, Medina D: Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution. Clin Cancer Res. 2008, 14: 370-378. 10.1158\/1078-0432.CCR-07-1127.","journal-title":"Clin Cancer Res"},{"key":"2865_CR30","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1200\/JCO.2007.14.5375","volume":"26","author":"HJ Burstein","year":"2008","unstructured":"Burstein HJ, Elias AD, Rugo HS, Cobleigh MA, Wolff AC, Eisenberg PD, Lehman M, Adams BJ, Bello CL, DePrimo SE, et al: Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. J Clin Oncol. 2008, 26: 1810-1816. 10.1200\/JCO.2007.14.5375.","journal-title":"J Clin Oncol"},{"key":"2865_CR31","first-page":"612","volume-title":"[Estrogen Receptor Determination in 537 Patients with Breast Cancer] Bulletin of Chinese Cancer","author":"XY Shi","year":"2002","unstructured":"Shi XY, Sheng M, Lu DP, Wang LJ: [Estrogen Receptor Determination in 537 Patients with Breast Cancer] Bulletin of Chinese Cancer. 2002, 11: 612-613."},{"key":"2865_CR32","first-page":"4","volume":"31","author":"JD Gao","year":"2009","unstructured":"Gao JD: [Characterization of hormone receptor status in 5758 Chinese females with breast cancer]. Chinese Journal of Oncology. 2009, 31: 4-","journal-title":"Chinese Journal of Oncology"},{"key":"2865_CR33","first-page":"1311","volume":"18","author":"JY Hu","year":"2010","unstructured":"Hu JY, Yin GW, Shen WD: [Relationship between mammographic feature and expression of ER, PR, C -erbB -2 in breast cancer]. Journal of Modern Oncology. 2010, 18: 1311-1313.","journal-title":"Journal of Modern Oncology"},{"key":"2865_CR34","first-page":"3","volume":"37","author":"HZ Qin","year":"2009","unstructured":"Qin HZ: [Relationship between the express of CerbB-2 and estrogen receptor, progesterone receptor, lymph node metastasis in breast cancer]. Modern Medical Journal. 2009, 37: 3-","journal-title":"Modern Medical Journal"},{"key":"2865_CR35","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10549-009-0462-6","volume":"120","author":"Z Fu","year":"2010","unstructured":"Fu Z, Li D, Jiang W, Wang L, Zhang J, Xu F, Pang D: Association of BTLA gene polymorphisms with the risk of malignant breast cancer in Chinese women of Heilongjiang Province. Breast Cancer Res Treat. 2010, 120: 195-202. 10.1007\/s10549-009-0462-6.","journal-title":"Breast Cancer Res Treat"},{"key":"2865_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/1097-0142(20010701)92:1<37::AID-CNCR1289>3.0.CO;2-F","volume":"92","author":"KC Chu","year":"2001","unstructured":"Chu KC, Anderson WF, Fritz A, Ries LA, Brawley OW: Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial\/ethnic groups. Cancer. 2001, 92: 37-45. 10.1002\/1097-0142(20010701)92:1<37::AID-CNCR1289>3.0.CO;2-F.","journal-title":"Cancer"},{"key":"2865_CR37","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3109\/07357907.2010.496759","volume":"28","author":"KA Cronin","year":"2010","unstructured":"Cronin KA, Harlan LC, Dodd KW, Abrams JS, Ballard-Barbash R: Population-based estimate of the prevalence of HER-2 positive breast cancer tumors for early stage patients in the US. Cancer Invest. 2010, 28: 963-968. 10.3109\/07357907.2010.496759.","journal-title":"Cancer Invest"},{"key":"2865_CR38","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1075-122x.2005.21463.x","volume":"11","author":"R Ariga","year":"2005","unstructured":"Ariga R, Zarif A, Korasick J, Reddy V, Siziopikou K, Gattuso P: Correlation of her-2\/neu gene amplification with other prognostic and predictive factors in female breast carcinoma. Breast J. 2005, 11: 278-280. 10.1111\/j.1075-122x.2005.21463.x.","journal-title":"Breast J"},{"key":"2865_CR39","first-page":"322","volume":"8","author":"TK Yau","year":"2002","unstructured":"Yau TK, Lau Y, Kong J, Yeung MW, Chan M, Sze WM, Cheung P, Lim BH, Lee A: Breast conservation treatment in Hong Kong-early results of 203 patients: retrospective study. Hong Kong Med J. 2002, 8: 322-328.","journal-title":"Hong Kong Med J"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-364.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-11-364\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-364","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-364.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T22:52:17Z","timestamp":1686264737000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-11-364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,22]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["2865"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-11-364","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,22]]},"assertion":[{"value":"11 May 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"364"}}